APM

Avidity Partners Management Portfolio holdings

AUM $347M
1-Year Est. Return 66.16%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+66.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$439M
AUM Growth
-$59.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
68
New
Increased
Reduced
Closed

Top Buys

1
+$37.3M
2
+$17.5M
3
+$12M
4
PFE icon
Pfizer
PFE
+$9.04M
5
KVUE icon
Kenvue
KVUE
+$5.41M

Top Sells

1
+$20.4M
2
+$18.7M
3
+$18.4M
4
HNGE
Hinge Health
HNGE
+$16.7M
5
BSX icon
Boston Scientific
BSX
+$16.3M

Sector Composition

1 Healthcare 99.02%
2 Consumer Staples 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KVUE icon
26
Kenvue
KVUE
$36.2B
$4.3M 0.98%
+265,200
IMUX icon
27
Immunic
IMUX
$126M
$4.14M 0.94%
4,699,411
-916,400
ARQT icon
28
Arcutis Biotherapeutics
ARQT
$3.04B
$4.04M 0.92%
214,400
-53,600
EXAS icon
29
Exact Sciences
EXAS
$19.7B
$4.03M 0.92%
73,600
-281,400
PHAT icon
30
Phathom Pharmaceuticals
PHAT
$892M
$3.6M 0.82%
306,000
-758,500
RGEN icon
31
Repligen
RGEN
$7.04B
$3.11M 0.71%
23,300
-83,200
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$3.86B
$3.07M 0.7%
+144,000
ASND icon
33
Ascendis Pharma
ASND
$14.9B
$2.88M 0.66%
+14,500
ELVN icon
34
Enliven Therapeutics
ELVN
$1.76B
$2.87M 0.65%
140,300
+129,000
BEAM icon
35
Beam Therapeutics
BEAM
$2.91B
$2.72M 0.62%
112,000
-297,400
SCYX icon
36
SCYNEXIS
SCYX
$31.5M
$2.58M 0.59%
3,350,528
+2,121,618
HQY icon
37
HealthEquity
HQY
$6.66B
$2.4M 0.55%
25,300
-66,700
WVE icon
38
Wave Life Sciences
WVE
$2.57B
$2.18M 0.5%
+297,500
XENE icon
39
Xenon Pharmaceuticals
XENE
$3.29B
$2.14M 0.49%
53,400
-54,491
AKRO
40
DELISTED
Akero Therapeutics
AKRO
$1.92M 0.44%
40,500
-93,500
INSM icon
41
Insmed
INSM
$31.2B
$1.67M 0.38%
11,600
-47,400
KPTI icon
42
Karyopharm Therapeutics
KPTI
$176M
$880K 0.2%
134,566
IMRX icon
43
Immuneering
IMRX
$325M
$636K 0.14%
+90,900
SPRY icon
44
ARS Pharmaceuticals
SPRY
$907M
– –
-140,000
KZR icon
45
Kezar Life Sciences
KZR
$51.5M
– –
-502,600
ALT icon
46
Altimmune
ALT
$520M
– –
-105,000
APGE icon
47
Apogee Therapeutics
APGE
$4.84B
– –
-65,000
AXSM icon
48
Axsome Therapeutics
AXSM
$8.5B
– –
-94,500
BBIO icon
49
BridgeBio Pharma
BBIO
$12.7B
– –
-140,000
CAH icon
50
Cardinal Health
CAH
$54.1B
– –
-15,000
1
2
3